Cargando…
Natriuretic Peptide Levels and Clinical Outcomes among Patients Hospitalized with COVID-19 Infection
PURPOSE: There is increasing evidence of adverse cardiovascular morbidity associated with SARS-CoV-2 (COVID-19). Pro-B-type natriuretic peptide (proBNP) is a biomarker of myocardial stress associated with outcomes in various respiratory and cardiac diseases. We hypothesized that proBNP level would b...
Autores principales: | Aslam, M.I., Minhas, A., Ghorbani, A., Shade, J., Jani, V., Hsu, S., Sharma, K., Cihakova, D., Hays, A., Gilotra, N.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979424/ http://dx.doi.org/10.1016/j.healun.2021.01.606 |
Ejemplares similares
-
Natriuretic Peptide Levels and Clinical Outcomes Among Patients Hospitalized With Coronavirus Disease 2019 Infection
por: Aslam, M. Imran, et al.
Publicado: (2021) -
The role of sex and inflammation in cardiovascular outcomes and mortality in COVID-19
por: Minhas, Anum S., et al.
Publicado: (2021) -
Real-Time Prediction of Mortality, Cardiac Arrest, and Thromboembolic Complications in Hospitalized Patients With COVID-19
por: Shade, Julie K., et al.
Publicado: (2022) -
B-YIA1-03 DEVELOPMENT AND VALIDATION OF A MULTI-VARIABLE MODEL FOR REAL-TIME PREDICTION OF CARDIAC ARREST AND OTHER CARDIOVASCULAR (CV) COMPLICATIONS IN HOSPITALIZED PATIENTS WITH COVID-19
por: Shade, Julie K., et al.
Publicado: (2021) -
The prognostic effect of brain natriuretic peptide levels on outcomes of hospitalized patients with COVID-19
por: Abdeen, Yazan, et al.
Publicado: (2021)